We aim at improving quality of life of millions of patients.
500 million people worldwide suffer from symptomatic osteoarthritis. Tendinopathies and ostearthritis (OA) are extremely common and have a direct impact in millions of people’s quality of life. Athletes, elderly and women are amongst the most affected.
In patients' lifes
Frequent joint pain often associated to deformation of the bones and muscle contractures.
Loss of mobility and autonomy which leads to great psycological wear.
Long-term postoperative rehabilitation.
A common and eroding health problem
exposed to progressive joint degeneration
over 60 affected by ostearthritis
procedures annually worldwide
Filling a critical gap
To date, non of existing surgical and non-surgical treatments provide with a full recovery of strength and functionality of the damaged tissue.
Seeking better and faster healing
We work for providing all patients with a new regenerative therapy for articular, tendinous or ligament diseases of weight-bearing joints.
↑ 10- %
functionality recovery ratios
Reduction of recovery time
3 STEPS TOWARDS
Decrease postoperative inflammatory response and risk of implant rejection
Mimic joint tissues properties and resist high forces quickly after implantation
Consolidate the integration of the graft to the native tissue
This project has received funding from the European Union’s Horizon 2020
research and innovation framework programme under the Grant Agreement #952981